Press release
Radionuclide Scanning Services Market: Global Drivers, Restraints, Opportunities, Trends & Forecast to 2025
Radionuclide scanning also called nuclear medicine imaging is the test that scans internal body parts with the use of radioactive material. This overcomes the limitations of standard X-Ray systems to reach and scan every body part. A radionuclide is used as a label to the substance that accumulates in specific part of the body such as Iodine is used to make thyroid hormones and thus accumulates in the thyroid glands similarly, Diphosphonate accumulates where bone is repairing or rebuilding itself. The tracer is swallowed, inhaled or injected under the skin which emits gamma rays, so the doctors can detect the location of tracer by the use of special scanners or cameras. Highly qualified personnel are required for this process.Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/16639
Radionuclide scanning can be used to visualize images in 2D using Scintigraphy technique as well as in 3D representation using SPECT. Some of the commonly used radionuclides for the service include Iodine-131, Yttrium-90, Samarium-153, Fluorine-18 and many others.
With the surge in the nuclear medicine imaging industry, the radionuclide scanning services market is also anticipated to increase during the forecast period. Furthermore, wide applications of the technique, painless diagnosis and in-depth analysis results in increasing the market. In most of the developing and under-developed countries, less popularity of the technique and high cost is the restraining factor for the market to grow in. The harmful effects of the radiations also hinders the growth in the diagnosis services market. Lack of skilled personnel for carrying out the diagnostic practices using radionuclide tracers is also a limiting factor in the market growth.
Large number of players in the market increases the competition. R&D activities, continuous innovation and improvisation of the technique also helps in moving the market ahead. Providing safe, cost effective and reliable services is the demand in the market. The brand name of various service providers are attracting the business. Various marketing strategies are adopted by the service providers to lure the doctors and patients for the services.
A geographic condition regarding the radionuclide scanning services market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest market share in the radionuclide scanning services due to large number of service providers in the region, good reimbursement scenario and health facilities in the reach of most of the population. This is followed by Europe because of better healthcare infrastructure and large number of government funded hospitals and laboratories. Asia-Pacific is still considered to be the growing segment because of increasing number of service providers in the region, but does not meet the high population density in the region.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/16639
The radionuclide service providers includes the hospitals and private laboratories. Some of the key players in the radionuclide scanning services market include Sonic Healthcare, Aditya Birla Health Services Ltd., Cleveland Clinic, The London Clinic, The GEL Group, Inc., Alliance Medical, Global Diagnostics and many others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radionuclide Scanning Services Market: Global Drivers, Restraints, Opportunities, Trends & Forecast to 2025 here
News-ID: 924746 • Views: …
More Releases from Persistence Market Research
North America Household Washer and Dryer Market Set to Reach US$ 22.2 Bn by 2032 …
The North America household washer and dryer market is poised for steady growth, supported by rising demand for smart home appliances, changing lifestyle patterns, and technological enhancements in laundry equipment. The market is projected to reach US$ 17.3 billion in 2025, and with a CAGR of 3.5% from 2025 to 2032, it is expected to climb to US$ 22.2 billion by 2032.
➤ Download Your Free Sample & Explore Key Insights:…
Indoor Plants Market to Grow at 5.4% CAGR Through 2032 as Demand for Green Inter …
The global indoor plants market is poised for sustained expansion over the next several years. According to Persistence Market Research, the market is projected to grow from US$ 22.6 billion in 2025 to US$ 32.7 billion by 2032, reflecting a CAGR of 5.4% during the forecast period. This upward trajectory underscores the increasing consumer shift toward wellness-driven living, biophilic interiors, and nature-connected home environments.
➤ Download Your Free Sample & Explore…
UV Disinfection Equipment Market Poised for Strong 16.3% CAGR Growth Through 203 …
The global UV disinfection equipment market is poised for remarkable expansion over the next decade. Industry estimates indicate that the market will be valued at US$ 17.0 billion in 2025 and is projected to surge to US$ 48.9 billion by 2032, registering a powerful CAGR of 16.3% between 2025 and 2032. This accelerated growth reflects heightened global focus on safety, hygiene, water quality, and chemical-free disinfection methods across both residential…
Surfing Apparel and Accessories Market Booms at 5.5% CAGR Through 2031, Reports …
The global surfing apparel and accessories market is set for steady expansion over the next several years. According to industry estimates, the market is anticipated to rise from US$ 9.5 billion in 2024 to US$ 14.1 billion by 2031, reflecting a healthy CAGR of 5.5% during the forecast period. This upward trajectory highlights the increasing global appeal of surfing as both a sport and a lifestyle.
➤ Download Your Free Sample…
More Releases for Radionuclide
Radionuclide Drug Conjugates (RDCs) Market Growth Set to Surge Significantly by …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook And Industry Analysis 2031"
The Global Radionuclide Drug Conjugates (RDCs) Market is expected to grow with a CAGR…
Radionuclide Therapy Equipment Market Size And Global Industry Forecast 2034
" In 2024, the global radionuclide therapy equipment market is valued at approximately $4.3 billion, driven by increasing prevalence of cancer and advancements in targeted therapies. The market is projected to reach around $7.8 billion by 2034, reflecting significant growth opportunities primarily attributed to technological advancements, enhanced diagnostic capabilities, and a rising focus on personalized medicine. "
Exactitude Consultancy., Ltd. released a research report titled "Radionuclide Therapy Equipment Market". This report…
Antibody-radionuclide Conjugates Market Share Research Report 2025
On Mar 6, 2025, Global Info Research released a research report titled "Global Antibody-radionuclide Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Antibody-radionuclide Conjugates market from 2020 to 2031. Including the market size and development trends of Antibody-radionuclide Conjugates Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a…
Radionuclide Drug Conjugates (RDCs) Market Robust Expansion is expected to 2031
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Peptide Receptor Radionuclide Therapy Market Analysis, Size, Current Scenario an …
Peptide Receptor Radionuclide Therapy Market is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of neuroendocrine tumors is expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. The establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT).
Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer…
